cost-effectiveness analysis

Also found in: Dictionary, Thesaurus, Legal, Financial, Encyclopedia, Wikipedia.

cost-effectiveness analysis (CEA)

a type of economic evaluation used to determine the best use of money available for medical care. It compares different kinds of interventions with similar, but not identical, effects on the basis of the cost per unit achieved.

cost-effectiveness analysis

Cost-utility analysis Clinical trials A form of economic analysis in which alternative interventions are compared in terms of the cost per unit of clinical effect–eg cost per life saved, per mm Hg of lowered BP, per yr of quality-adjusted life gained, etc Health care policy Analysis related to the effectiveness of therapies or interventions and their associated costs. Cf Cost-benefit analysis.


pertaining to cost-effective.

cost-effectiveness analysis
a comparison of the relative cost-efficiencies of two or more ways of performing a task or achieving an objective.
References in periodicals archive ?
Prospective Cost-Effectiveness Analysis of Cetuximab in Metastatic Colorectal Cancer: Evaluation of National Cancer Institute of Canada Clinical Trials Group CO.
Not performing cost-effectiveness analysis While the EPA did review estimated costs and benefits of its proposed standards, it failed to evaluate whether its regulations are actually a cost-effective approach to achieve its regulatory goals.
Cost-effectiveness analysis and weighted cost-effectiveness analysis are used to compare alternatives that are equally effective in achieving a stated goal or standard (Needleman 1969; Ruegg and Marshal, 1990; Balchin et al.
Thus, in conducting a cost-effectiveness analysis, it is crucial to consider the necessity of these expenses and the overall cost of implementation on the efficacy of treatment.
The Disease Control Priorities Project, the subject of our cover story, "Best Buys for Public Health," uses cost-effectiveness analysis to identify the most efficient interventions to improve health in the developing world.
Application of cost-effectiveness analysis to multiple products: A practical guide.
Part I includes eight chapters on global health policy ranging from topics such as implications of multilateral trade agreements, public-private health partnerships, regulation in the context of global health markets, healthcare financing reform and policies, as well as cost-effectiveness analysis.
and, Cost-effectiveness analysis and priority-setting: global approach without local message?
Pharmacy benefit management, cost-effectiveness analysis and drug formulary decisions.
In this analysis, this issue was interpreted in terms of the increased ability to predict patient prognosis; alternatively, quality-adjusted life-years (QALYs) could be incorporated into a cost-effectiveness analysis.